SCHEMBL6103166

SCHEMBL6103166

COc1cc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)[C@@H]1CCN1C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.67
ERBB2 P04626 11/20 0.63
LCK P06239 1/20 0.60
ERBB4 Q15303 4/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2252480 0.96 EGFR (0.66) EGFRERBB2LCKERBB4
SCHEMBL2249784 0.93 EGFR (0.75) EGFRERBB2LCKERBB4
SCHEMBL2250704 0.89 EGFR (0.57) EGFRERBB2LCK
SCHEMBL2249394 0.89 EGFR (0.73) EGFRERBB2LCKERBB4
SCHEMBL6102692 0.89 EGFR (0.57) EGFRERBB2LCKERBB4
SCHEMBL2247127 0.88 EGFR (0.69) EGFRERBB2LCKERBB4
SCHEMBL2248785 0.88 EGFR (0.72) EGFRERBB2LCKERBB4
SCHEMBL6104551 0.88 EGFR (0.56) EGFRERBB2LCK
SCHEMBL2255364 0.86 EGFR (0.68) EGFRERBB2LCK
SCHEMBL2251599 0.85 EGFR (0.67) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006071079-A1 QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2006-07-06 WO disclosed